ClinicalTrials.gg
RecruitingNCT07767812Updated Aug 17, 2026

Effects of Motivational Interviewing on Pain Self-Efficacy and Exercise Behavior in Individuals With Knee Osteoarthritis

An interventional study of Motivational Interviewing and Neuromuscular Exercise Program in Knee Arthritis Osteoarthritis, sponsored by Kutahya Health Sciences University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2026-08-17.

Sponsored by Kutahya Health Sciences University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Feb 2026, registered Aug 2026).
  • Started Feb 2026; still recruiting 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
40 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-12

Among 268 studies in Osteoarthritis, Knee with a site in Turkey — 54 open to participants now, 66 under way, 3 of them phase 3. Osteoarthritis, Knee · Turkey.

Planned enrollment
117th of 198
56 · median 60
Started
2026
with 37 others
No phase
189 of 268
31 open now
Primary completion
2026-11
later than 34 of 65 live
Registered
251st of 268
by date

Among the 268 studies in Osteoarthritis, Knee with a site in Turkey, this one is the 117th largest by planned enrollment of the 198 interventional ones, is one of 38 that started in 2026, is one of 189 with no phase, reaches primary completion later than 34 of the 65 other live ones, and was the 251st registered.

By phase

268 studies; the count open now beside each. This study's row is marked.

No phasethis study189 · 31 open
Observational70 · 21 open
Phase 44 · 0 open
Phase 33 · 2 open
Phase 11 · 0 open
Phase 21 · 0 open

By the year they started

First in 2006; this study’s year is marked. 38 started in 2026.

Size and results

Median enrollment 60 across the 198 interventional studies, 84 across the 70 observational. Of the 180 that completed or were terminated, 3 (2%) have results posted.

Was this useful?
Watch this landscapeDownload CSVWith an account: a weekly mail of what changed among 268 studies in Osteoarthritis, Knee with a site in Turkey, or all of them as a file.
02

Study summary

This randomized controlled trial aims to investigate the effects of motivational interviewing added to a neuromuscular exercise and home exercise program on pain self-efficacy, exercise behavior, pain intensity, physical performance, and functional status in individuals with knee osteoarthritis. Sixty individuals diagnosed with knee osteoarthritis will be randomly allocated to either an intervention group or a control group. The intervention group will receive motivational interviewing in addition to neuromuscular exercise and a home exercise program, whereas the control group will receive neuromuscular exercise and the same home exercise program. Outcomes will be assessed at baseline, immediately after the intervention, and six weeks after the intervention.

03

Conditions studied

  • Knee Arthritis Osteoarthritis

Keywords

  • KNEE OSTEOARTHRITIS
  • MOTIVATIONAL INTERVIEWING
  • EXERCISE
04

Who can participate

Ages eligible
40 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of knee osteoarthritis according to American College of Rheumatology (ACR) criteria
  • Kellgren-Lawrence radiographic grade ≥2
  • Knee pain lasting longer than 3 months

Exclusion criteria

Exclusion Criteria:

  • History of joint arthroplasty
  • >40 kg/m²
  • Neuromuscular or neurological diseases such as stroke, Parkinson's disease, or multiple sclerosis
  • History of lower-extremity joint fracture
  • Hip osteoarthritis
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
56 participants (estimated)

Study arms

  • Experimental
    Motivational Interviewing + Neuromuscular Exercise + Home Exercise

    Participants in this group will receive motivational interviewing in addition to a supervised neuromuscular exercise program and a home exercise program.

    Behavioral: Motivational Interviewing · Other: Neuromuscular Exercise Program · Other: Home Exercise Program

  • Active comparator
    Neuromuscular Exercise Program

    Participants will perform neuromuscular exercise sessions five times per week for four weeks. Each 60-minute session will consist of approximately 10 minutes of warm-up, 40 minutes of exercise, and 10 minutes of cool-down. Exercises will include core stabilization and postural control, postural orientation, lower-extremity strengthening, functional exercises, and balance and proprioception exercises. Exercises will be progressed according to participant tolerance and functional performance.

    Other: Neuromuscular Exercise Program · Other: Home Exercise Program

Interventions

  • BehavioralMotivational Interviewing

    Motivational interviewing will be delivered individually in face-to-face sessions by a researcher trained and certified in motivational interviewing. Sessions will focus on identifying individual barriers and goals, strengthening motivation and commitment to exercise, supporting self-efficacy, and preventing relapse. The intervention will incorporate three stages: increasing exercise motivation, strengthening commitment to exercise, and relapse prevention.

  • OtherNeuromuscular Exercise Program

    Participants will perform neuromuscular exercise sessions five times per week for four weeks. Each 60-minute session will consist of approximately 10 minutes of warm-up, 40 minutes of exercise, and 10 minutes of cool-down. Exercises will include core stabilization and postural control, postural orientation, lower-extremity strengthening, functional exercises, and balance and proprioception exercises. Exercises will be progressed according to participant tolerance and functional performance.

  • OtherHome Exercise Program

    The home exercise program will include isometric strengthening exercises for the quadriceps and hip adductor muscles, straight leg raising, assisted hip and knee flexion, and active knee flexion exercises. Participants will perform the program five days per week, twice daily, for three weeks, with 10 repetitions of each exercise. The program will be explained and demonstrated by a physiotherapist during the first session, and adherence will be followed by telephone contact.

06

What researchers measure

Primary outcomes

  1. The Exercise Self-Efficacy Scale (ESE)

    The Exercise Self-Efficacy Scale (ESE) measures a person's confidence in their ability to maintain regular physical activity or exercise when facing various internal and external barriers. Different validated versions exist, including Albert Bandura's 18-item scale, an older adult 9-item scale, and a 10-item spinal cord injury adaptation.

    Time frame: Baseline, immediately after the 4-week intervention, and 6 weeks after completion of the intervention

  2. Pain Self-Efficacy Questionnaire (PSEQ)

    The Pain Self-Efficacy Questionnaire (PSEQ) is a 10-item self-report tool designed to measure a person's confidence in performing daily activities and functioning normally despite ongoing chronic pain. It uses a 7-point scale from 0 to 6, yielding total scores between 0 and 60, where higher scores reflect stronger coping confidence.

    Time frame: Baseline, immediately after the 4-week intervention, and 6 weeks after completion of the intervention

Secondary outcomes

  1. Numerical Pain Rating Scale

    The Numeric Pain Rating Scale (NPRs) is a fast, 11-point tool used to measure pain intensity. Patients select a whole number from 0 (no pain) to 10 (worst pain imaginable) to rate their discomfort verbally or in writing.

    Time frame: Baseline, immediately after the 4-week intervention, and 6 weeks after completion of the intervention

  2. The WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index)

    The WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) is a widely used, self-administered 24-item questionnaire that evaluates pain (5 items), stiffness (2 items), and physical function (17 items) in patients with knee or hip osteoarthritis.

    Time frame: Baseline, immediately after the 4-week intervention, and 6 weeks after completion of the intervention.

  3. Physical Performance 30-Second Sit-to-Stand Test (30s STS)

    The 30s STS measures lower-extremity functional strength by recording the total number of complete sit-to-stand repetitions performed within 30 seconds, with a higher number of repetitions indicating better performance.

    Time frame: Baseline, immediately after the 4-week intervention, and 6 weeks after completion of the intervention

  4. Physical performance timed up and go test (TUG)

    The TUG measures functional mobility as the time, in seconds, required to stand up from a chair, walk 3 meters, turn, walk back, and sit down, with a shorter completion time indicating better performance.

    Time frame: Baseline, immediately after 4 week intervention and 6 weeks after competition of the intervention

  5. Physical performance 40-meter Walking Test

    The 40mWT assesses walking speed by recording the time required to complete a 40-meter walking course, with a shorter completion time indicating better walking performance. The results of the three tests will be reported separately and will not be combined into a composite score.

    Time frame: Baseline, immediately after the 4-week intervention, and 6 weeks after completion of the intervention

07

Study locations

1 of 1 sites recruiting
  • AFSÜ Health Application and Research Center, Department of Physical Therapy and Rehabilitation
    Afyonkarahisar, Türkiye 03100, Turkey (Türkiye)
    Recruiting
    • Aynur EYVAZ, MD · Contactaynureyvaz@afsu.edu.tr · 00902742651100
    • İbrahim YUKSEL, Msc. · Principal investigator
    • Ismail Saracoglu, Phd · Principal investigator
    • Nuray EYVAZ, MD · Sub investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2026 (actual). Primary completion is estimated for Nov 2026, 9 months after the start.

Of 1,111 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 9 months is below that.

Counting every sponsor, half of 1,251 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 11, 2026
First posted
Aug 17, 2026
StartActual
Feb 1, 2026
Primary completionEst.
Nov 15, 2026
CompletionEst.
Dec 31, 2026
Last update
Aug 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07767812
Responsible party
Ismail Saracoglu (Head of Department, Kutahya Health Sciences University) — Principal investigator
First posted
Aug 17, 2026
Start date
Feb 1, 2026
Primary completion
Nov 15, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Aug 17, 2026

Study contacts

İbrahim YUKSEL, Msc. PT
Contact
ibrahimyuksel0308@gmail.com
0539 222 88 46

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion